BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 38634056)

  • 1. Contrast-enhanced ultrasound combined with elastic imaging for predicting the efficacy of concurrent chemoradiotherapy in cervical cancer: a feasibility study.
    Ma Y; Zhao X; Chen X
    Front Oncol; 2024; 14():1301900. PubMed ID: 38634056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strain elastography imaging for early detection and prediction of tumor response to concurrent chemo-radiotherapy in locally advanced cervical cancer: feasibility study.
    Xu Y; Zhu L; Liu B; Ru T; Wang H; He J; Liu S; Yang X; Zhou Z; Liu T
    BMC Cancer; 2017 Jun; 17(1):427. PubMed ID: 28629386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Value of contrast-enhanced ultrasound combined with elastography in evaluating cervical lymph node metastasis in papillary thyroid carcinoma.
    Jiang W; Wei HY; Zhang HY; Zhuo QL
    World J Clin Cases; 2019 Jan; 7(1):49-57. PubMed ID: 30637252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application Value of Ultrasound Elastography Combined With Contrast-Enhanced Ultrasound (CEUS) Quantitative Analysis in Differentiation of Nodular Fibrocystic Changes of the Breast From Invasive Ductal Carcinoma.
    Li J; Wu Y; Tian Z; Shu L; Wu S; Wu Z
    Ultrason Imaging; 2024 Mar; 46(2):102-109. PubMed ID: 38098206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strain elastography as an early predictor of long-term prognosis in patients with locally advanced cervical cancers treated with concurrent chemoradiotherapy.
    Xu Y; Zhu L; Zhu L; Wang H; Ru T; Liu B; He J; Tian S; Zhou Z; Yang X
    Eur Radiol; 2020 Jan; 30(1):471-481. PubMed ID: 31359126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study on value of ultrasonic elastography in diagnosis of clinical staging of cervical cancer and efficacy evaluation of radiotherapy.
    Zhang Y; Yan Y; Yang Y
    Oncol Lett; 2019 Jun; 17(6):4901-4906. PubMed ID: 31186698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Posttreatment squamous cell carcinoma antigen predicts treatment failure in patients with cervical squamous cell carcinoma treated with concurrent chemoradiotherapy.
    Wang W; Liu X; Hou X; Lian X; Liu Z; Shen J; Sun S; Yan J; Miao Z; Wang D; Meng Q; Fu J; Zhang F; Qiu J; Hu K
    Gynecol Oncol; 2019 Nov; 155(2):224-228. PubMed ID: 31500891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of serum squamous cell carcinoma antigen for follow-up monitoring of cervical cancer patients who were treated by concurrent chemoradiotherapy.
    Yoon SM; Shin KH; Kim JY; Seo SS; Park SY; Moon SH; Cho KH
    Radiat Oncol; 2010 Sep; 5():78. PubMed ID: 20840788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical values of squamous cell carcinoma antigen and carcinoembryonic antigen in patients with cervical cancer treated with concurrent chemoradiotherapy.
    Yoon SM; Shin KH; Kim JY; Seo SS; Park SY; Kang S; Cho KH
    Int J Gynecol Cancer; 2007; 17(4):872-8. PubMed ID: 17343571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Average log change rate of pretreatment squamous cell carcinoma antigen after concurrent chemoradiotherapy in stage IIIC1 cervical squamous cell carcinoma.
    Cho O; Chun M; Chang SJ
    Sci Rep; 2024 Apr; 14(1):8710. PubMed ID: 38622276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endu combined with concurrent chemotherapy and radiotherapy for stage IIB-IVA cervical squamous cell carcinoma patients.
    Zhao FJ; Su Q; Zhang W; Yang WC; Zhao L; Gao LY
    World J Clin Cases; 2021 Sep; 9(27):8061-8070. PubMed ID: 34621863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can serial evaluation of serum SCC-Ag-level predict tumor recurrence and patient survival in squamous-cell carcinoma of uterine cervix treated with definitive chemoradiotherapy? A multi-institutional analysis.
    Choi KH; Yu M; Jeong S; Lee JH
    Int J Clin Oncol; 2020 Jul; 25(7):1405-1411. PubMed ID: 32221801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of Short-Term Imaging and Squamous Cell Carcinoma Antigen to Early Predict Response to Concurrent Chemoradiotherapy in Patients With Cervical Cancer.
    Yoo JG; Kim SI; Yeo SG; Park DC
    Cancer Control; 2022; 29():10732748221074530. PubMed ID: 35196888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Application value of texture analysis of magnetic resonance images in prediction of neoadjuvant chemoradiotherapy efficacy for rectal cancer].
    Shu Z; Fang S; Ding Z; Mao D; Pang P; Gong X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Sep; 21(9):1051-1058. PubMed ID: 30269327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Irreversible electroporation of hepatocellular carcinoma: preliminary report on the diagnostic accuracy of magnetic resonance, computer tomography, and contrast-enhanced ultrasound in evaluation of the ablated area.
    Granata V; de Lutio di Castelguidone E; Fusco R; Catalano O; Piccirillo M; Palaia R; Izzo F; Gallipoli AD; Petrillo A
    Radiol Med; 2016 Feb; 121(2):122-31. PubMed ID: 26345332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Application of endoscopic tattooing with carbon nanoparticlet in the treatment for advanced colorectal cancer].
    Wang R; Zhan HL; Li DZ; Li HT; Yu L; Wang W
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Jan; 23(1):56-64. PubMed ID: 31958932
    [No Abstract]   [Full Text] [Related]  

  • 17. Nomograms for predicting prognostic value of combined neutrophil-to-lymphocyte ratio and SCC-Ag in locally advanced cervical cancer.
    Jin L; Cao F; Zhang Y; Dang Y; Wang F
    Transl Cancer Res; 2024 Mar; 13(3):1323-1335. PubMed ID: 38617514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum squamous cell carcinoma antigen level and magnetic resonance imaging for the prognosis of locally advanced cervical cancer.
    Gu LN; Yu JW; Jiang L; Liu TB; Xu Y
    Eur Rev Med Pharmacol Sci; 2024 Jan; 28(2):668-678. PubMed ID: 38305609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of squamous cell carcinoma antigen (SCC Ag) in outcome prediction after concurrent chemoradiotherapy and treatment decisions for patients with cervical cancer.
    Fu J; Wang W; Wang Y; Liu C; Wang P
    Radiat Oncol; 2019 Aug; 14(1):146. PubMed ID: 31416463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognostic value of squamous cell carcinoma antigen for predicting tumor recurrence in cervical squamous cell carcinoma patients.
    Ryu HK; Baek JS; Kang WD; Kim SM
    Obstet Gynecol Sci; 2015 Sep; 58(5):368-76. PubMed ID: 26430661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.